PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

[PR Newswire] – BIRMINGHAM, England, April 29, 2014 /PRNewswire/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with mult more

View todays social media effects on CTIC

View the latest stocks trending across Twitter. Click to view dashboard

See who Cell is hiring next, click here to view